MDXG vs RCL · P/E 18, rev $123.4M vs P/E 26, rev $9.28B
MiMedx Group Inc (MDXG) versus Royal Caribbean Cruises Ltd (RCL) — a side-by-side from cached financials, not a winner call.
MiMedx Group Inc (MDXG) is a biotechnology company listed on US.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
Latest reported MDXG revenue for 2026-06-30 was $123.4M. Net income was -$25.7M. MDXG currently screens at market cap $537.7M and trailing P/E 18.1.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
MDXG currently screens at market cap $537.7M and trailing P/E 18.1. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Not investment advice. Open the MDXG and RCL stock pages for the full models.
Not investment advice.